Reference to what was published in the news under “Avigan® Approved for COVID-19 Treatment in Malaysia”, Agility would like to announce that the Malaysian Ministry of Health’s Drug Control Authority has approved Avigan® for use in treatment of COVID-19 patients.
Earlier this year, Global Response Aid (GRA), an affiliate of Agility, and Dr. Reddy’s Laboratories signed an agreement for exclusive global production, distribution and commercialization of the drug with its developer, FujiFilm Toyama Chemical.
Agility cannot assess the financial impact at the moment.
Get real-time air & ocean freight quotes and access to a powerful dashboard.
Kuwait-based Agility Logistics Parks customers can log-on to view contracts and make payments.
UK MOD personnel can log-in to the GRMS portal to schedule household relocation shipments.
Get real-time air & ocean freight quotes and access to a powerful dashboard.
Kuwait-based Agility Logistics Parks customers can log-on to view contracts and make payments.
UK MOD personnel can log-in to the GRMS portal to schedule household relocation shipments.
How Better Warehouses Increase Trade in Africa
Learn More
Download Report
Get real-time air & ocean freight quotes and access to a powerful dashboard.
Kuwait-based Agility Logistics Parks customers can log-on to view contracts and make payments.
UK MOD personnel can log-in to the GRMS portal to schedule household relocation shipments.
Get real-time air & ocean freight quotes and access to a powerful dashboard.
Kuwait-based Agility Logistics Parks customers can log-on to view contracts and make payments.
UK MOD personnel can log-in to the GRMS portal to schedule household relocation shipments.
Commenting on published news
Reference to what was published in the news under “Avigan® Approved for COVID-19 Treatment in Malaysia”, Agility would like to announce that the Malaysian Ministry of Health’s Drug Control Authority has approved Avigan® for use in treatment of COVID-19 patients.
Earlier this year, Global Response Aid (GRA), an affiliate of Agility, and Dr. Reddy’s Laboratories signed an agreement for exclusive global production, distribution and commercialization of the drug with its developer, FujiFilm Toyama Chemical.
Agility cannot assess the financial impact at the moment.
Sincerely,
Investor Relations Team
Latest Financial News
March 23, 2025
Supplemental Disclosure related to a Short-Term Facility
March 16, 2025
Clarification of the News
March 16, 2025
Supplementary Disclosure Related to Legal Cases
March 13, 2025
Commencement of the nomination period for Agility’s Board of Directors
March 11, 2025
Refinancing of Current Credit Facilities
March 9, 2025
Supplemental Disclosure related to a Convertible Loan